Phase II multicentric uncontrolled national trial assessing the efficacy of nilotinib in the treatment of advanced melanomas with c-KIT mutation or amplification.

Affiliation auteurs!!!! Error affiliation !!!!
TitrePhase II multicentric uncontrolled national trial assessing the efficacy of nilotinib in the treatment of advanced melanomas with c-KIT mutation or amplification.
Type de publicationJournal Article
Year of Publication2014
AuteursLebbe C, Chevret S, Jouary T, Dalac S, Dalle S, Guillot B, Arnault J-P, Avril M-F, Bedane C, Bens G, -Beylot-Barry M, Mansard S, Grange F, Meyer N, Machet L, Misery L, Saiag P, Battistella M, Mourah S, Dumaz N, Cuta GCCGrp Franca
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume32
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/jco.2014.32.15_suppl.9032